Abstract

The development of positron emission tomography (PET) and the use of radiotracers designed for the study of cerebral blood flow and metabolism have provided new insights into central nervous system function in vivo. Particularly in the case of Parkinson’s disease, different approaches have permitted a broader understanding of dopaminergic neurotransmission and the changes that take place during the progressive loss of dopaminergic neurons of the substantia nigra. In this chapter, we review physiological aspects of dopamine metabolism, as well as the patterns of alterations observed in Parkinson’s disease and related forms of parkinsonism. Studies of cerebral metabolism during performance of motor behaviors and insights derived from imaging into the complications of long term levodopa treatment (fluctuations and dyskinesias) will also be considered.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.